Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJardine Math.sr Regulatory News (JAR)

Share Price Information for Jardine Math.sr (JAR)

Share Price is delayed by 15 minutes
Get Live Data
62.50    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 0.00 (0.00%)
Market Cap: $18.42b
JAR Live PriceLast checked at - London Stock Exchange

Intraday Jardine Math.sr Share Chart

Interim Management Statement

10 Nov 2022 09:42

RNS Number : 9939F
Mandarin Oriental International Ltd
10 November 2022
 

Announcement

 

The following announcement was issued today to a Regulatory Information Service approved by the Financial Conduct Authority in the United Kingdom.

 

MANDARIN ORIENTAL INTERNATIONAL LIMITED

Interim Management Statement

 

10th November 2022 - Mandarin Oriental International Limited today issues its Interim Management Statement for the third quarter of 2022.

 

The return of normal travel conditions in most of the world in early 2022 saw the Group record net underlying profits (unaudited) in the second quarter, and this progress continued in the third quarter.

 

In the Group's owned hotels, improvements in occupancy and high rates resulted in a stronger performance in the third quarter. This drove increased profitability compared to the second quarter, particularly in Paris and Munich. Two of the Group's key profit-generating hotels, in Hong Kong and Tokyo, however, remained subject to stringent travel restrictions throughout the third quarter, which significantly impacted operating performance. The hotels in Bangkok and Singapore continued their recovery following the removal of travel barriers.

 

The performance of the management business was strong in the third quarter and it recorded a significant improvement in profitability compared to the second quarter. Of particular note were the contributions made by a number of the Group's Mediterranean and Middle Eastern properties.

 

As a result of the improved trading conditions and Mandarin Oriental's expanded portfolio of hotels and residences, the Group recorded its highest quarterly EBITDA since 2019. Both the owned hotels and the management business delivered higher EBITDA than in the second quarter of 2022.

 

In September 2022, the Group opened Mandarin Oriental Palace, Luzern, its second hotel in Switzerland, and its standalone residences project in Barcelona. Recently, the Group announced a new hotel in Tianfu, the new business district of Chengdu, further expanding its presence in China. On 8th September 2022, the Group completed the sale of Mandarin Oriental, Washington D.C., for US$139 million. As a result, the Group has recognised a post-tax, non-trading gain in the third quarter of US$47 million.

 

Following the disposal, net debt at 30th September 2022 reduced to US$385 million (US$519 million at 30th June 2022), and the Group held US$267 million of cash reserves and US$472 million in available, committed debt facilities. Gearing was 8% of adjusted shareholders' funds.

 

Mandarin Oriental International Limited is incorporated in Bermuda and has a primary listing in the standard segment of the London Stock Exchange, with secondary listings in Bermuda and Singapore. Mandarin Oriental is a member of the Jardine Matheson Group.

 

- end -

 

For further information, please contact:

Mandarin Oriental Hotel Group International Limited

James Riley

(852) 2895 9288

Matthew Bishop

(852) 2895 9288

Brunswick Group Limited

William Brocklehurst

(852) 5685 9881

 

This and other Group announcements can be accessed through the Internet at 'www.mandarinoriental.com'.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DOCKBLBFLFLXFBK
Date   Source Headline
29th Jul 202110:23 amRNS2021 HALF YEAR FINANCIAL STATEMENTS
29th Jul 202110:22 amRNS2021 Half Yearly Results
29th Jul 202110:19 amRNSPT Hero Supermarket Tbk First Half 2021 Results
30th Jun 202110:22 amRNSReport on Payments to Govts
30th Jun 202110:20 amRNSTotal Voting Rights
4th Jun 202110:42 amRNSDirector/PDMR Shareholding
2nd Jun 202110:35 amRNSDirector/PDMR Shareholding
1st Jun 20217:05 amRNSTotal Voting Rights
12th May 202110:23 amRNSDirector/PDMR Shareholding
10th May 202110:21 amRNSAdditional Listing
6th May 202112:18 pmRNSResult of AGM
6th May 202110:20 amRNSInterim Management Statement
5th May 202110:24 amRNSInterim Management Statement
5th May 202110:23 amRNSInterim Management Statement
5th May 202110:22 amRNSInterim Management Statement
4th May 20217:00 amRNSDividend
30th Apr 202111:03 amRNSPT Hero Supermarket Tbk First Quarter 2021 Results
30th Apr 202110:33 amRNSTotal Voting Rights
29th Apr 202112:58 pmRNSDirector/PDMR Shareholding
28th Apr 202111:07 amRNSDividend
27th Apr 202110:34 amRNSJC&C Interim Management Statement
21st Apr 202110:45 amRNSPT Astra 2021 First Quarter Financial Statements
16th Apr 202110:26 amRNSHolding(s) in Company
16th Apr 202110:25 amRNSHolding(s) in Company
16th Apr 202110:24 amRNSHolding(s) in Company
15th Apr 20218:26 amRNSCancellation of Listing of Jardine Strategic
15th Apr 20217:00 amRNSCompletion of Acquisition of JSH by JMH
12th Apr 20211:25 pmRNSUpdate on Simplification of JM & Acquisition of JS
8th Apr 202110:25 amRNSAnnual Financial Report
7th Apr 202110:20 amRNSCirc re. Scrip Dividend Scheme
31st Mar 202110:57 amRNSTotal Voting Rights
25th Mar 20219:36 amRNSBlock listing Interim Review
24th Mar 20219:32 amRNSDirector Declaration
18th Mar 20217:00 amRNSCir re. Publication of Shareholder Circular
11th Mar 202111:23 amRNS2020 Preliminary Announcement of Results
11th Mar 20219:16 amRNS2020 Preliminary Announcement of Results
11th Mar 20219:16 amRNS2020 Preliminary Announcement of Results
11th Mar 20219:16 amRNS2020 Preliminary Announcement of Results
10th Mar 20219:38 amRNSFull Year 2020 Results of PT Hero
8th Mar 20217:00 amRNSRecommended Cash Acquisition of Jardine Strategic
8th Mar 20217:00 amRNSSimplification of Jardine Matheson Structure
26th Feb 202110:08 amRNSJardine Cycle & Carriage – Final Results
26th Feb 20219:30 amRNSTotal Voting Rights
25th Feb 20219:54 amRNSAstra International - Final Results
9th Feb 20219:39 amRNSDirector/PDMR Shareholding
8th Feb 202111:16 amRNSTransaction in Own Shares
1st Feb 202111:33 amRNSTransaction in Own Shares
29th Jan 202110:45 amRNSTotal Voting Rights
29th Jan 202110:43 amRNSTransaction in Own Shares
28th Jan 20219:45 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.